tiprankstipranks
Advertisement
Advertisement
Xbrane Biopharma Announces SEK 200 Million Directed Share Issue
PremiumCompany AnnouncementsXbrane Biopharma Announces SEK 200 Million Directed Share Issue
2M ago
Xbrane Biopharma Strengthens Focus with Sale of XB003 to Alvotech
Premium
Company Announcements
Xbrane Biopharma Strengthens Focus with Sale of XB003 to Alvotech
2M ago
Xbrane Biopharma Advances Biosimilar Candidate Towards FDA Approval
Premium
Company Announcements
Xbrane Biopharma Advances Biosimilar Candidate Towards FDA Approval
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100